Funding Rounds
ImCheck Therapeutics Unknown (2022, $102M)
ImCheck TherapeuticsPlatform developing new treatments that focus on the butyrophilin family's checkpoint molecules.
Summary
Stage: Unknown
Raised Amount: $102.30M
Raised Date: 2022-01-01
Stage: Unknown
Raised Amount: $102.30M
Raised Date: 2022-01-01
